Crossfire Debates: 2-Drug Versus 3-Drug Regimens for HIV

Crossfire Debates: 2-Drug Versus 3-Drug Regimens for HIV is organized by Prime Education, LLC.

Intended Audience:
Physicians, Psychologists, Nurse Practitioners, Physician Assistants, Nurses, Pharmacists, Case Managers, and Health Education Specialists.

Release Date: August 23, 2019
Expiration Date: August 22, 2020

Accreditation:
• 1.0 CE for Physicians (AMA Category 1)
• 1.0 CE for Psychologists
• 1.0 CE for Physician Assistants
• 1.0 CE for Nurse Practitioners
• 1.0 CE for Pharmacists (Automatic NABP)
• 1.0 CE for Case Managers (CCMC)
• 1.0 CE for Health Education Specialists

Learning Objectives:
• Differentiate new and emerging antiretroviral therapies (ARTs) for efficacy, safety, and adherence potential
• Evaluate evidence from head-to-head clinical trials on 2-drug versus 3-drug regimens for HIV
• Apply evidence-based and expert guidance for simplifying and switching antiretroviral therapy (ART)

Additional details will be posted as soon as information is available.